What's breaking now, across thousands of outlets.
China-based drugmaker Haisco Pharmaceutical has been on a dealmaking tear this summer, and its latest alliance is with two dominant names in biotech. The biopharma is teaming with Bob Nelsen’s ARCH Venture Partners and Clive ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
New parents expect to lose sleep, but a new longitudinal study reveals that early postpartum depression and anxiety can predict worse perceived sleep quality months later, creating a cycle of distress…
(MedPage Today) -- The FDA cleared the Elecsys pTau217 blood test to identify amyloid-beta pathology associated with Alzheimer's disease in people ages 55 and older with symptoms of cognitive decline…
Ziihera plus tislelizumab and chemotherapy approved for first-line treatment of all HER2+ GEA patients (IHC 3+ and IHC 2+/ISH+) regardless of PD-L1 status, providing a new treatment option in…
